FDA’s innovation challenge

The Food and Drug Administration is accepting proposals from developers aimed at encouraging the development of medical devices or with existing product aimed at detecting, treating and preventing opioid addiction. FDA’s device center will choose which applicants are accepted into the program and those selected will have “enhanced interactions with FDA review divisions” during the development of their products. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.